Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has issued an update.
Vitrafy Life Sciences Limited has announced the cessation of John McBain as a director as of November 20, 2025. The final director’s interest notice reveals McBain’s holdings in the company, including ordinary shares and unlisted options, through various entities. This change in directorship may impact the company’s governance and strategic direction.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Average Trading Volume: 26,392
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$93.86M
For a thorough assessment of VFY stock, go to TipRanks’ Stock Analysis page.